Leningrad Nuclear Power Plant

The Leningrad Nuclear Power Plant (LNPP) is a major nuclear power generation facility in Russia that serves as a critical global supplier of medical radioisotopes for the healthcare and life sciences industries. Operated by Rosenergoatom, a subsidiary of Rosatom, the plant utilizes its RBMK-1000 channel-type reactors to produce a wide array of isotopes, including Molybdenum-99, Iodine-131, Iodine-125, and Lutetium-177. These materials are essential for diagnostic imaging, targeted radionuclide therapy in oncology, and the sterilization of medical devices via Cobalt-60 production. LNPP is a key node in the international radiopharmaceutical supply chain, providing the raw materials necessary for the treatment of millions of patients worldwide. The facility continues to expand its medical isotope portfolio to support emerging therapeutic modalities in nuclear medicine.